Cabaletta Bio (CABA) Retained Earnings (2018 - 2026)

Cabaletta Bio's Retained Earnings history runs 8 years deep, the most recent figure standing at -$517.0 million for Q4 2025.

• In Q4 2025, Retained Earnings fell 48.08% year-over-year to -$517.0 million; the TTM figure through Dec 2025 stood at -$517.0 million (down 48.08% YoY), while the FY2025 annual figure was -$517.0 million, down 48.08% from the prior year.
• Retained Earnings for Q4 2025 stood at -$517.0 million, down from $23000.0 in the prior quarter.
• The five-year high for Retained Earnings was $39000.0 in Q4 2023, with the low at -$517.0 million in Q4 2025.
• The 5-year median for Retained Earnings is -$92.9 million (2021), against an average of -$126.0 million.
• The sharpest annual moves came in 2022 and 2023: Retained Earnings plunged 4184533.33% in 2022, then surged 182.98% in 2023.
• Cabaletta Bio's Retained Earnings stood at -$112.6 million in 2021, then soared by 99.96% to -$47000.0 in 2022, then soared by 182.98% to $39000.0 in 2023, then tumbled by 895230.77% to -$349.1 million in 2024, then plunged by 48.08% to -$517.0 million in 2025.
• Business Quant data shows CABA's Retained Earnings at -$517.0 million in Q4 2025, $23000.0 in Q3 2025, and $1000.0 in Q2 2025.